Abstract
Cytomegalovirus retinitis is a rare complication in kidney transplant patients with only one other reported incidence. A 70-year-old female with a previous history of kidney transplant began experiencing a decreased vision of her right eye and was diagnosed with CMV retinitis and started on ganciclovir treatment. After completing the treatment, the patient has had no signs of recurrence or any other complaints. There is only one other published case report of CMV retinitis in a kidney transplant patient, therefore appropriate treatment and predictability of recurrence are unknown.
Keywords: Cytomegalovirus, retinitis, kidney transplant, diagnosis, ganciclovir treatment, CMV.
Infectious Disorders - Drug Targets
Title:Cytomegalovirus Retinitis Diagnosis and Treatment in a Kidney Transplant Recipient
Volume: 20 Issue: 6
Author(s): Victoria Oakes, Dinesh Bahl and Suresh Antony*
Affiliation:
- Texas Tech University Health Sciences Center, El Paso and Southwest Retina Associates, El Paso, Texas, TX,United States
Keywords: Cytomegalovirus, retinitis, kidney transplant, diagnosis, ganciclovir treatment, CMV.
Abstract: Cytomegalovirus retinitis is a rare complication in kidney transplant patients with only one other reported incidence. A 70-year-old female with a previous history of kidney transplant began experiencing a decreased vision of her right eye and was diagnosed with CMV retinitis and started on ganciclovir treatment. After completing the treatment, the patient has had no signs of recurrence or any other complaints. There is only one other published case report of CMV retinitis in a kidney transplant patient, therefore appropriate treatment and predictability of recurrence are unknown.
Export Options
About this article
Cite this article as:
Oakes Victoria , Bahl Dinesh and Antony Suresh *, Cytomegalovirus Retinitis Diagnosis and Treatment in a Kidney Transplant Recipient, Infectious Disorders - Drug Targets 2020; 20 (6) . https://dx.doi.org/10.2174/1871526519666191111100826
DOI https://dx.doi.org/10.2174/1871526519666191111100826 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
COVID-19 in Pediatrics: A Diagnostic Challenge
Current Pediatric Reviews Cardiac Workup of Ischemic Stroke
Current Cardiology Reviews MicroRNAs in CAG Trinucleotide Repeat Expansion Disorders: an Integrated Review of the Literature
CNS & Neurological Disorders - Drug Targets The Toxicogenetics of Antirretroviral Therapy: The Evil Inside
Current Medicinal Chemistry Contemporary Animal Models For Human Gene Therapy Applications
Current Gene Therapy Exploring Current Role of Nanotechnology Used in Food Processing Industry to Control Food Additives and their Biochemical Mechanisms
Current Drug Targets CCR1 and CCR2 Antagonists
Current Topics in Medicinal Chemistry Neonatal Fever in the Term Infant: Evaluation and Management Strategies
Current Pediatric Reviews Stress Hormone-Mediated DNA Damage Response -- Implications for Cellular Senescence and Tumour Progression
Current Drug Targets P2X7 Receptors: Channels, Pores and More
CNS & Neurological Disorders - Drug Targets Michael Acceptors as Cysteine Protease Inhibitors
Mini-Reviews in Medicinal Chemistry Recent Patents Regarding Essential Oils and the Significance of their Constituents in Human Health and Treatment
Recent Patents on Anti-Infective Drug Discovery Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
Current Rheumatology Reviews Systemic DNA Damage Response and Metabolic Syndrome as a Premalignant State
Current Molecular Medicine Pharmacogenetic Aspects of Therapy with Cholinesterase Inhibitors: The Role of CYP2D6 in Alzheimers Disease Pharmacogenetics
Current Alzheimer Research Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders <i>Ajuga</i> L.: A Systematic Review on Chemical Composition, Phytopharmacological and Biological Potential
Current Bioactive Compounds Editorial
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Modulation of Toll-Like Receptor 4. Insights from X-Ray Crystallography and Molecular Modeling
Current Topics in Medicinal Chemistry Clinical Use of Clopidogrel
Current Pharmaceutical Design